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Abstract The DmsD protein is essential for the biogenesis of
DMSO reductase in Escherichia coli, and binds the signal pep-
tide of the DmsA subunit, a Tat substrate. This suggests a role
as a guidance factor to target pre-DmsA to the translocase.
Here, we have analysed the export of fusion proteins in which
the DmsA and TorA signal peptides are fused to green £uores-
cent protein. Both chimeras are e⁄ciently exported to the peri-
plasm in wild-type E. coli cells and we show that their export
e⁄ciencies are essentially identical in a mutant lacking DmsD.
An authentic Tat substrate, TMAO reductase, is also e⁄ciently
exported in the dmsD mutant. The data indicate that DmsD
carries out a critical role in DMSO reductase biogenesis/assem-
bly but is not required for the functioning of the DmsA signal
peptide.
' 2002 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
In Escherichia coli the majority of exo-cytoplasmic proteins
are transported from their site of synthesis to their subcellular
destination via the Sec pathway. These proteins, which are
made as precursors with an amino-terminal signal peptide,
are threaded through an integral membrane protein complex
in an energy-dependent, unfolded state [1]. Recently, another
protein translocation system has been discovered in the cyto-
plasmic membrane of E. coli and many other bacteria (for
review see [2]). This complementary pathway was denoted
the Twin-arginine translocase (Tat) pathway, as substrates
transported via this route possess an essential twin-arginine
motif in their signal peptides. In contrast to the well-charac-
terised Sec pathway, which transports only unfolded proteins,
the Tat system uses an entirely di¡erent mechanism and has
the unique ability to transport fully folded proteins across
coupled membranes [3,4].
Prime examples of Tat substrates in E. coli are a range of
proteins that acquire redox cofactors, such as iron^sulphur
and molybdopterin centres, in the cytoplasm prior to trans-
port [5^7]. One such protein is the molybdopterin cofactor-
containing DmsA, which is the catalytic subunit of the en-
zyme dimethyl sulfoxide (DMSO) reductase. Additional sub-
units in the membrane-associated enzyme are DmsB, an iron^
sulphur protein and DmsC, which acts as a membrane an-
chor. DMSO reductase is a terminal electron transfer enzyme
which enables anaerobic respiratory growth of E. coli on me-
dia containing an electron donor/carbon source, such as glyc-
erol, and the electron acceptor DMSO [8].
The E. coli Tat system consists of four tat genes, three of
which (tatABC) form an operon while the fourth gene (tatE)
is monocistronic. Knockout studies have shown that Tat-de-
pendent export requires minimally TatB [7,9], TatC [9] and
either TatA or TatE [10,11]. TatA, B and E contain a single
transmembrane span with a small C-terminal domain exposed
on the cis face of the membrane (i.e. the cytoplasm in bac-
teria, or stroma in chloroplasts [12]), whereas TatC contains
four transmembrane regions with the N- and C-termini local-
ised in the cytoplasm [13].
No additional membrane-bound Tat subunits have been
identi¢ed to date and a complex of 600 kDa comprising
only TatA, B and C has been puri¢ed from solubilised E.
coli membranes [14]. However, Oresnik et al. [15] recently
tested whether other components are involved in the secretion
of proteins containing a twin-arginine (RR) signal peptide.
Using the DmsA twin-arginine leader as a probe they identi-
¢ed two proteins that interacted with this protein in E. coli :
DmsD and DnaK. The DmsD protein contains 204 amino
acids, and in vitro characterisation of this protein showed
that it interacts with the precursor form of DmsA. DmsD
also interacts with the precursor form of a second Tat sub-
strate, TorA (trimethyl amine N-oxide (TMAO) reductase).
These data point to an important role for DmsD, possibly
as a guidance factor for RR-signal peptides that may ensure
delivery to the translocase. In this work we have further char-
acterised the role of DmsD in the transport of proteins via the
Tat pathway. We show that the DmsA signal peptide can
function e⁄ciently in the absence of DmsD and that a related
Tat substrate, TMAO reductase, is e⁄ciently exported in the
DmsD mutant strain. The data point to an essential role for
DmsD in the activity or assembly of DMSO reductase, but
not in the functioning of the DmsA signal peptide.
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2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
E. coli strains used in this work were TG1 [16], a wild-type strain,
TALB01, a DmsD null mutant [14] and vtatABCDE which has been
described before [17]. E. coli was aerobically grown at 37‡C in modi-
¢ed low salt Luria broth (lsLB) [18], or anaerobically in lsLB-GT
medium, consisting of lsLB supplemented with glycerol (0.5%),
TMAO (0.4%), and ammonium molybdate (1 WM), or in minimal
TMAO/glycerol medium or minimal DMSO/glycerol medium [19].
Medium supplements were used at the following ¢nal concentrations:
ampicillin, 100 Wg/ml; kanamycin, 50 Wg/ml; arabinose 100 WM.
To generate a vector encoding the DmsA pre-sequence fused to
green £uorescent protein (GFP), the GFP gene sequence was ampli-
¢ed from the plasmid pJDT1 [18] using primers GFP1F (ccggaatt-
catgtctaaaggagaagaactt) and GFP1R (ctctcaagcttatttgtatagttcatc-
catgc). These primers introduced a unique EcoRI site upstream of
the GFP start codon and a unique HindIII site downstream of the
stop codon; these sites are underlined. The resulting PCR product
was cloned into the EcoRI^HindIII-digested pBAD24 vector [20], re-
sulting in the plasmid pBAD-GFP. The DmsA pre-sequence was am-
pli¢ed from total chromosomal DNA with primers dmsaF (gcaagctt-
gaattccccattatg) and dmsaR (ggaatggcgaattcgacagcgtg), with EcoRI
restriction sites underlined. The resulting PCR product was digested
with EcoRI and cloned into the EcoRI-digested pBAD-GFP plasmid,
generating pBAD-DmsAGFP, in which the DmsA pre-sequence is
fused to GFP.
2.2. Cell fractionations
Cells were grown aerobically (in lsLB) or anaerobically (in lsLB-
GT) medium in the presence or absence of arabinose (as stated in the
text). Periplasm and spheroplasts were prepared by the EDTA/lyso-
zyme/cold osmotic shock procedure [21]. Spheroplasts were lysed by
sonication, and intact cells and cellular debris were removed by cen-
trifugation (5 min at 10 000Ug). Membranes were separated from the
cytoplasmic fraction by centrifugation (30 min at 250 000Ug). Protein
concentration was determined using a BCA-linked assay (Pierce). Pro-
tein fractions were separated on a 10% non-denaturing polyacryl-
amide gel, allowing detection of TMAO reductase activity via a gel-
based methyl viologen-linked assay [22], or were separated by SDS^
PAGE and immunoblotted with speci¢c antibodies to GFP (Clontech)
and horseradish peroxidase anti-rabbit IgG conjugates, using the ECL
detection system (Amersham Pharmacia Biotech).
2.3. Microscopy
E. coli strains containing pJDT1 or pBAD-DmsAGFP were grown
aerobically at 37‡C in lsLB containing 100 WM arabinose. After 2 h
incubation, cells were pelleted, washed with lsLB, and resuspended in
fresh lsLB. After a further 1 h incubation, 500 Wl of cells was collected
by centrifugation and washed with lsLB. These cells were mounted
onto poly-L-lysine-treated microscope slides (Sigma) and examined by
phase contrast and £uorescence (£uorescein isothiocyanate ¢lter set)
microscopy. Images were taken with a Zeiss Axiovert 200 microscope
equipped with a Quantix camera containing a 1536U1024 pixel and
9 Wm pitch chip (Digital Pixel Advanced Imaging Systems). The digital
images were processed using METAMORPH version 4.6.4 (Universal
Imaging Corp.) and the ¢les were exported to Microsoft Powerpoint
for printing.
3. Results and discussion
3.1. DmsD is required for anaerobic growth using DMSO
To further investigate the role DmsD plays in protein tar-
geting to the Tat complex, the DmsD-minus mutant,
TALB01, was grown anaerobically on minimal glycerol me-
dium in the presence of DMSO and growth was monitored
over a 4-day period. Fig. 1 shows a typical growth curve for
the wild-type TG1 strain, whereas the vtatABCDE strain fails
to grow under these conditions, as expected since targeting of
the DmsA subunit is blocked. Fig. 1 shows that the dmsD
mutant also fails to grow, indicating that DmsD is required
for DMSO reductase function, as found previously. The dmsD
mutant is able to grow on TMAO, although growth is slightly
reduced for unknown reasons (data not shown), which further
suggests that the defect may be speci¢c for DMSO reductase.
3.2. TMAO reductase localisation is not a¡ected by DmsD
deletion
To investigate more directly the consequences of the DmsD
deletion, we next analysed the distribution of a known Tat
substrate, TorA, in the dmsD mutant. This was achieved using
native gels in which the TorA activity is visualised directly in
the polyacrylamide gel, using a methyl viologen-linked assay.
Fig. 2 shows that the majority of active TorA is localised in
the periplasm in wild-type cells, as expected and shown pre-
viously [6]. In contrast, in a strain lacking all known Tat
Fig. 1. Anaerobic growth of TG1, vtatABCDE and vdmsD. E. coli
strains vtatABCDE (E), wild-type (F) and vdmsD (R) were grown
anaerobically on minimal glycerol medium in the presence of
DMSO and growth was monitored using OD600 measurements over
a 4-day period.
Fig. 2. Localisation of TMAO reductase activity in the vdmsD mutant. E. coli strains vtatABCDE (vtat), wild-type and vdmsD were grown an-
aerobically and fractionated into periplasmic (P), cytoplasmic (C) or membrane (M) samples. The samples were analysed by native gel electro-
phoresis and TMAO reductase activity was visualised in the gel, as detailed in Section 2.
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components (vtatABCDE), all of the active TorA is present in
the cytoplasm, showing the complete block of TorA export
(vtat panel). The results obtained with the dmsD mutant
strain show that the vast majority of active TorA is localised
in the periplasm. These results show that the DmsD protein is
not absolutely required for correct localisation of TMAO re-
ductase.
3.3. The DmsA RR-signal peptide targets GFP to the periplasm
in the dmsD mutant
The above data show that the Tat system is functioning in
the dmsD mutant, at least for TorA export, and so the im-
portant question is whether DmsD is speci¢cally required for
the targeting of DmsA through an interaction with the DmsA
signal peptide. It should be emphasised that the ¢nal destina-
tion of DmsA is a matter of debate [7,9]. However, targeting
of the DmsAB subunits into the mature DMSO reductase
enzyme complex requires a functional Tat system and process-
ing of the DmsA leader peptide [7,23]. While DmsC is widely
agreed to be located in the membrane, the subcellular location
of DmsA in particular is controversial. It has been proposed
that DmsA and B are located on the cytoplasmic face of the
inner bacterial membrane, based on a combination of tech-
niques including DmsA^ and DmsB^PhoA fusions [7,24,25].
However, in the absence of the membrane anchor DmsC,
DMSO reductase activity was predominantly located in the
periplasmic fraction. DmsB was also located primarily in the
periplasm and, because this subunit is not synthesised with a
signal peptide, it was suggested that it may be targeted and
exported by virtue of its interaction with DmsA [26].
DMSO activity is absent in the dmsD mutant [15], suggest-
ing that DmsD may indeed be required for targeting of
DmsA/DmsB to the Tat system. However, it is important to
establish whether DmsD is a true ‘guidance factor’, which
simply recognizes the DmsA signal and initiates targeting to
the translocase, or whether it plays a distinct role in the over-
all biogenesis of this enzyme. We addressed these questions by
generating a chimeric protein in which GFP is linked to the
DmsA signal peptide. Previous studies [18,27] have shown
that the TorA signal peptide is able to direct the export of
GFP exclusively by the Tat pathway, and studies on this
TorA^GFP chimera were also carried out to determine
whether the lack of DmsD a¡ects export e⁄ciency; this
GFP-based export assay is generally more quantitative than
the TorA native gel assay shown in Fig. 2.
In order to examine its export, synthesis of DmsA^GFP
was induced with 100 WM arabinose and cells were fraction-
ated. The localisation of the GFP was monitored by immuno-
Fig. 3. DmsA^GFP and TorA^GFP are e⁄ciently exported in the
vdmsD mutant. E. coli strains vtatABCDE (vtat), wild-type and
vdmsD containing either pBAD-DmsAGFP (expressing pre-DmsA^
GFP; panel A), or pJDT1 (expressing TorA^GFP; panel B), were
grown for 2 h in the presence of 100 WM L-arabinose. Cells were
fractionated to yield periplasmic (P), cytoplasmic (C) and membrane
(M) samples and immunoblotted using antibodies to GFP. Mature-
size GFP and the GFP precursor proteins are indicated.
Fig. 4. Localisation of GFP by £uorescence microscopy. E. coli wild-type, vtatABCDE and vdmsD cells expressing TorA^GFP (A, B and C re-
spectively) or DmsA^GFP (D, E and F respectively) were grown aerobically for 2 h in the presence of 100 WM L-arabinose, followed by 1 h in-
cubation after the removal of arabinose, after which they were examined using £uorescence microscopy as detailed in Section 2.
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blotting and Fig. 3A shows that in wild-type TG1 cells the
majority of the GFP is found in the periplasmic fraction (lane
P) as the mature form. Some mature-size GFP is also found in
the cytoplasmic fraction (lane C), apparently from proteolysis
of the signal peptide [18]. In the vtatABCDE strain (vtat
panel) there is no export of DmsA^GFP to the periplasm,
as expected, and precursor/degradation forms are found in
the cytoplasm (C) and membrane (M) fractions. The ¢nal
panel shows that DmsA^GFP is e⁄ciently exported to the
periplasm in the dmsD mutant lacking DmsD (vdmsD panel),
and repeat experiments (not shown) have shown the export
e⁄ciency to be consistently as high as in wild-type cells. The
total amount of GFP is slightly lower in the dmsD cells, but
this is not always the case and the signi¢cance of this point is
therefore unclear.
The export of TorA^GFP in dmsD mutant cells is shown in
Fig. 3B. The data show that the export of TorA^GFP in the
dmsD strain is again comparable with that observed in wild-
type cells, with the majority of protein found as mature GFP
in the periplasm in both cases. No export is observed in the
vtatABCDE control panel. Thus, the combined data in Fig. 3
indicate that DmsD is not required for the e⁄cient export of a
protein bearing either the DmsA or TorA signal peptides,
suggesting that DmsD is required for DMSO reductase activ-
ity or assembly, rather than the targeting of DmsA to the
bacterial inner membrane.
3.4. Imaging of GFP
The results presented above show that GFP can be ex-
ported to the periplasm of E. coli cells when GFP is fused
to either of two Tat-substrate signal peptides. To test the
localisation of GFP more directly, cells over-expressing
TorA^GFP or DmsA^GFP were examined by £uorescence
microscopy and the data are shown in Fig. 4. Wild-type cells
(A and D) and the dmsD mutant strain (C and F) showed
prominent halos of GFP localised in the periplasm with both
GFP constructs. In contrast, and as expected, the vtatABCDE
strain (B and E) showed a clear cytoplasmic location of GFP
and the typical chain-like phenotype of this mutant.
3.5. Conclusions
The DmsD protein carries out an essential function in the
biogenesis of DMSO reductase and has the ability to bind to
the DmsA signal peptide in vitro [15]. These properties sug-
gested a role as a guidance factor functioning in the targeting
of this subunit (and perhaps the associated DmsB protein) to
the Tat apparatus. In this report we have analysed the role of
DmsD using chimeric proteins, and the data show clearly that
DmsD is not required for the functioning of the DmsA signal
peptide under the conditions studied here. In the absence of
DmsD, DmsA^ and TorA^GFP fusions are exported with
high e⁄ciency, as is TMAO reductase, indicating that these
signal peptides are fully operational. These data e¡ectively
rule out a role as a guidance factor and point to a very di¡er-
ent role for the DmsD protein.
One possibility is that DmsD is required for cofactor inser-
tion during DMSO reductase assembly. Sequence compari-
sons show that DmsD is related to, if not a member of, the
TorD family of proteins (R.J. Turner and F. Sargent, unpub-
lished observations). TorD has been proposed to be a chap-
erone protein speci¢c for TorA, involved in the insertion of
the cofactor into the apoprotein [28]. TorA and DmsA are
homologous proteins, each binding a molybdopterin cofactor,
and it therefore seems likely that the DmsD and TorD pro-
teins may have similar functions. It is also possible that a
chaperone function of DmsD may involve its binding to the
signal peptide of DmsA; while we have shown that DmsA^
GFP can be exported in the absence of DmsD, it is certainly
possible that the binding of DmsD to pre-DmsA may in£u-
ence its assembly. Binding may also inhibit export to some
extent (although a substantial inhibition or block is ruled out
since our data show that this signal peptide functions correctly
in dmsD mutant cells). This would be an e⁄cient means of
preventing export of the protein prior to assembly, although
there is evidence that the homologous TorD protein binds to
the mature region of TorA [29]. In summary, our data point
to an essential function of DmsD in the assembly of DMSO
reductase but not in the functioning of the DmsA or TorA
signal peptides.
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